NCT05940493 2026-03-13
Abemaciclib in Newly Diagnosed Meningioma Patients
St. Joseph's Hospital and Medical Center, Phoenix
Phase 2 Recruiting
Clinical Trials
49 trialsNCT06104930 2026-03-10
MOLI
University Hospital Heidelberg
Phase NA Recruiting
NCT05425004 2026-03-05
Cabozantinib for Patients With Recurrent or Progressive Meningioma
Baptist Health South Florida
Phase 2 Recruiting
NCT02523014 2026-03-04
Vismodegib, FAK Inhibitor GSK2256098, Capivasertib, and Abemaciclib in Treating Patients With Progressive Meningiomas
Alliance for Clinical Trials in Oncology
Phase 2 Recruiting
NCT06377371 2026-02-27
Feasibility of Intraoperative Tracing of Meningioma Using [Cu64]DOTATATE
Weill Medical College of Cornell University
Phase 4 Recruiting
NCT06878469 2026-02-19
SIMPLIF-AI
Fondazione I.R.C.C.S. Istituto Neurologico Carlo Besta
Phase NA Recruiting
NCT04278118 2026-02-17
HiPPI
Emory University
Phase NA Recruiting
NCT06955169 2026-02-17
MOMENTUM-1
RTOG Foundation, Inc.
Phase 2 Recruiting
NCT07411690 2026-02-17
CSF-IMR
Medical University of Warsaw
Recruiting
NCT05957679 2026-02-12
MRE Evaluation for Spinal Cord Tumor Surgery: Stiffness and Adhesion Assessment
Shengjing Hospital
Phase NA Recruiting
NCT06955208 2026-02-12
3D MRE-Based Evaluation of Meningioma Mechanical Properties and Histological Features
Shengjing Hospital
Phase NA Recruiting
NCT06132685 2026-02-10
Post-Operative Dosing of Dexamethasone in Patients With Brain Tumors After a Craniotomy, PODS Trial
Emory University
Phase 2 Recruiting
NCT07282470 2026-02-10
MIND
Fondazione I.R.C.C.S. Istituto Neurologico Carlo Besta
Recruiting
NCT05139277 2026-02-06
Evaluation of the CONVIVO System
Dartmouth-Hitchcock Medical Center
Phase NA Recruiting
NCT06650163 2026-02-05
Zr-89 Crefmirlimab Berdoxam and Immuno-Positron Emission Tomography for the Imaging of Patients With Resectable Brain Tumors
Jonsson Comprehensive Cancer Center
Phase 1 Recruiting
NCT03180268 2026-01-14
Observation or Radiation Therapy in Treating Patients With Newly Diagnosed Grade II Meningioma That Has Been Completely Removed by Surgery
NRG Oncology
Phase 3 Recruiting
NCT07150806 2025-12-22
RYZ101 for the Treatment of Progressive or Recurrent Intracranial Meningioma
Ohio State University Comprehensive Cancer Center
Phase 1/2 Recruiting
NCT04082520 2025-12-11
Lutathera for the Treatment of Inoperable, Progressive Meningioma After External Beam Radiation Therapy
Mayo Clinic
Phase 2 Recruiting
NCT04081701 2025-11-21
DOMINO-START
Weill Medical College of Cornell University
Phase 4 Recruiting
NCT06930846 2025-11-21
HOBSCOTCH-CA
Dartmouth-Hitchcock Medical Center
Phase NA Recruiting
NCT05278208 2025-10-20
Lutathera for Treatment of Recurrent or Progressive High-Grade CNS Tumors
Nationwide Children's Hospital
Phase 1/2 Recruiting
NCT04638478 2025-09-29
PREselection of Patients at Risk for COgnitive DEcline After Radiotherapy Using Advanced MRI
Maastricht Radiation Oncology
Recruiting
NCT06831461 2025-09-16
PRIDE
Tata Memorial Centre
Phase NA Recruiting
NCT06632860 2025-07-09
A Dual-targeting Tracer TATE-RGD for the Diagnosis of SSTR- and RGD- Positive Tumors
Peking Union Medical College Hospital
Phase EARLY_PHASE1 Recruiting
NCT07056023 2025-07-09
EURJMT
University Hospital Muenster
Recruiting
NCT04087902 2025-07-03
Long-Term Longitudinal QoL in Patients Undergoing EEA
Ohio State University
Recruiting
NCT07044076 2025-06-29
MenQOL
Centre Hospitalier St Anne
Recruiting
NCT06036706 2025-06-24
CANCER-COG
Centre Francois Baclesse
Phase NA Recruiting
NCT05416567 2025-06-05
e-men
St. Olavs Hospital
Phase NA Recruiting
NCT06014905 2025-05-25
Feasibility of Acquiring Hyperpolarized Imaging in Patients With Meningioma
University of California, San Francisco
Phase 1 Recruiting
NCT06874426 2025-04-23
Endo-Olfact
Universitaire Ziekenhuizen KU Leuven
Recruiting
NCT04659811 2025-04-17
Stereotactic Radiosurgery and Immunotherapy (Pembrolizumab) for the Treatment of Recurrent Meningioma
University of California, San Francisco
Phase 2 Recruiting
NCT04997317 2025-04-13
PROMENADE
University Hospital, Basel, Switzerland
Phase 1/2 Recruiting
NCT05793034 2025-03-13
23Men
Fondazione Policlinico Universitario Agostino Gemelli IRCCS
Phase NA Recruiting
NCT06275919 2025-03-13
MIRAGE
Istituto Oncologico Veneto IRCCS
Phase 2 Recruiting
NCT06126588 2025-03-11
ELUMEN
Central Hospital, Nancy, France
Phase 2 Recruiting
NCT06830356 2025-02-17
SPIDER-MEN
Centro di Riferimento Oncologico - Aviano
Phase NA Recruiting
NCT06710249 2025-01-27
AFBTEdema
Skane University Hospital
Phase 2 Recruiting
NCT06557512 2025-01-08
SRS-AIM
University of California, San Francisco
Phase NA Recruiting
NCT06466720 2024-12-11
CoDeB-Rad
University of Nottingham
Recruiting
NCT05254197 2024-12-03
SOLOMON
Seoul National University Hospital
Recruiting
NCT04648462 2024-11-26
Proton Therapy Research Infrastructure- ProTRAIT- Neuro-oncology
Maastricht Radiation Oncology
Recruiting
NCT06684795 2024-11-12
FG001 in Subjects with Meningiomas or Presumed Low-Grade Gliomas Scheduled for Neurosurgery
Rigshospitalet, Denmark
Phase 2 Recruiting
NCT06640582 2024-11-05
BAH2472
Essen Biotech
Phase 1/2 Recruiting
NCT06607692 2024-10-21
LUPARPED
Fundación de investigación HM
Phase 2 Recruiting
NCT04501705 2024-10-15
Apatinib in the Treatment of Recurrent Atypical/malignant Meningioma in Adults
Beijing Sanbo Brain Hospital
Phase NA Recruiting
NCT03631953 2024-08-06
ALTREM
Assistance Publique Hopitaux De Marseille
Phase 1 Recruiting
NCT05576103 2024-06-18
Longitudinal Prospective Study of Neurocognition & Neuroimaging in Primary BT Patients
University of California, San Diego
Recruiting
NCT05727605 2024-05-08
NARCiS
Universitaire Ziekenhuizen KU Leuven
Phase NA Recruiting